Showing results (311-320 of 322) with videos related to
Sort By:
Pageof 33
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.Journal of the American College of Cardiology|September 1, 2024
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.International Journal of Stroke : Official Journal of the International Stroke Society|January 7, 2022
Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progressCraig S Anderson, Anthony Rodgers, H Asita de Silva, et al.Diabetologia|July 6, 2021
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose controlJohanne Tremblay, Mounsif Haloui, Redha Attaoua, et al.Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.Journal of the American Heart Association|August 24, 2022
Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of HypertensionSonali R Gnanenthiran, Claudio Borghi, Dylan Burger, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.Journal of the American College of Cardiology|December 14, 2020
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 StudyGregory A Roth, George A Mensah, Catherine O Johnson, et al.Pageof 33